Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer.
Phase of Trial: Phase III
Latest Information Update: 01 Oct 2018
At a glance
- Drugs Samarium 153 lexidronam (Primary) ; Calcium; Strontium-89; Vitamin D analogues; Zoledronic acid
- Indications Advanced breast cancer; Bone metastases; Lung cancer; Prostate cancer
- Focus Registrational; Therapeutic Use
- 03 Apr 2018 Status changed from active, no longer recruiting to completed.
- 01 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 13 Jan 2011 Last checked against University of Southern California Norris Comprehensive Cancer Center record.